HighTower Advisors LLC Sells 3,099 Shares of Danaher Corporation (NYSE:DHR)

Key Points

• HighTower Advisors LLC has reduced its stake in Danaher Corporation by 0.9%, now holding 349,626 shares worth approximately $71.67 million.
• During the first quarter, several institutional investors increased their holdings in Danaher, with some reporting significant percentage increases; for instance, GHP Investment Advisors' stake rose 396%.
• Danaher Corporation's recent earnings report showed a 3.4% year-over-year revenue increase to $5.94 billion, along with an EPS of $1.80, surpassing analyst expectations.

HighTower Advisors LLC lowered its stake in Danaher Corporation (NYSE:DHR - Free Report) by 0.9% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 349,626 shares of the conglomerate's stock after selling 3,099 shares during the quarter. HighTower Advisors LLC's holdings in Danaher were worth $71,673,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of the stock. FAS Wealth Partners Inc. lifted its holdings in Danaher by 20.6% during the 4th quarter. FAS Wealth Partners Inc. now owns 9,597 shares of the conglomerate's stock worth $2,203,000 after buying an additional 1,639 shares during the last quarter. MGO One Seven LLC lifted its holdings in shares of Danaher by 485.7% in the 1st quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate's stock worth $5,145,000 after purchasing an additional 20,813 shares during the last quarter. Asahi Life Asset Management CO. LTD. bought a new stake in shares of Danaher in the 1st quarter worth approximately $539,000. Horizon Financial Services LLC lifted its holdings in shares of Danaher by 20,400.0% in the 1st quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate's stock worth $1,681,000 after purchasing an additional 8,160 shares during the last quarter. Finally, EFG Asset Management Americas Corp. lifted its holdings in shares of Danaher by 13.1% in the 1st quarter. EFG Asset Management Americas Corp. now owns 36,080 shares of the conglomerate's stock worth $7,396,000 after purchasing an additional 4,191 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Stock Up 0.3%

NYSE DHR traded up $0.62 during trading on Friday, hitting $210.84. 3,210,213 shares of the company traded hands, compared to its average volume of 4,658,279. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $279.90. The business has a fifty day simple moving average of $199.94 and a 200 day simple moving average of $199.87. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $150.97 billion, a P/E ratio of 44.86, a PEG ratio of 2.93 and a beta of 0.73.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%. The company had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. During the same period last year, the company earned $1.72 earnings per share. The business's revenue was up 3.4% compared to the same quarter last year. As a group, sell-side analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Analyst Upgrades and Downgrades

DHR has been the topic of several analyst reports. Robert W. Baird raised their target price on Danaher from $225.00 to $226.00 and gave the company an "outperform" rating in a research report on Friday, July 18th. JPMorgan Chase & Co. lowered their target price on Danaher from $280.00 to $260.00 and set an "overweight" rating on the stock in a research report on Tuesday, April 22nd. Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a research report on Friday, June 27th. Royal Bank Of Canada reiterated an "outperform" rating and set a $250.00 price target on shares of Danaher in a research report on Wednesday, April 23rd. Finally, HSBC lowered their price target on Danaher from $270.00 to $240.00 in a research report on Friday, April 25th. Three investment analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company. According to data from MarketBeat.com, Danaher has an average rating of "Moderate Buy" and an average price target of $247.61.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.